Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3524| Title: | Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis | Authors: | Holtmann, Gerald Shah, A. Johnson, K. M. Lewindon, P. Alrabadi, L. Fischer, R. T. |
Issue Date: | 2021 | Source: | 74, (3), 2021, p. 1716-1717 | Pages: | 1716-1717 | Journal: | Hepatology | Abstract: | L20115826012021-05-28 | DOI: | 10.1002/hep.31764 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L2011582601&from=exporthttp://dx.doi.org/10.1002/hep.31764 | | Keywords: | intestine flora;letter;magnetic resonance cholangiopancreatography;morbidity;mortality;primary sclerosing cholangitis;prospective study;diarrhea;ulcerative colitis;child;antibiotic therapy;ursodeoxycholic acidvancomycin;randomized controlled trial (topic);disease activity;drug efficacy;fatigue;follow up;human;informed consent | Type: | Article |
| Appears in Sites: | Children's Health Queensland Publications Gastroenterology and Hepatology, Princess Alexandra Hospital |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.